Good afternoon folks, welcome to this edition of weekend reading, we close out the month with a podcast from the August issue of Gastroenterology & Hepatology.
Dr. Kuemmerle along with Dr. Fasiha Kanwal discuss SVR rates using first generation DAA therapies, current agents, and what we can expect in the future. In addition, access to treatment is examined with an emphasis on making HCV treatment more affordable to everyone.
Evolution of Hepatitis C Virus Treatment
Evolution of Hepatitis C Virus Treatment
No comments:
Post a Comment